The activist has secured board representation and a first-lien on assets, giving it significant control over the company's strategic direction and capital allocation. Watch for the Trust to push for a sale, restructuring, or other value realization event given the company's Nasdaq non-compliance and distressed financial state. The $2.915M additional note option expires September 30, 2027, providing a timeline for potential further escalation.
Price Chart
Executive Summary
The Philip & Daniele Barach Family Trust filed Amendment No. 3 to its Schedule 13D, reporting a significant escalation in its activist position at Celularity. The Trust purchased a $3.21M senior secured convertible note and warrants on September 24, 2026, and entered into a Board Rights Agreement giving it the right to designate two directors (Philip Barach was appointed on September 24). The Trust's beneficial ownership is now 9,491,270 shares (24.5% of outstanding common), up from the prior filing. This is a clear escalation: the activist is injecting new capital, securing board seats, and obtaining a first-priority security interest over substantially all of the company's assets, signaling high conviction and a timeline measured in months.
Key Financial Metrics
Key Facts
- Trust purchased $3,210,000 senior secured convertible note (September 2026 Convertible Note) and warrants for 1,177,000 shares at $1.50/share.
- Trust has option to purchase up to $2,915,531 in additional convertible notes and up to 1,457,765 additional warrants at $2.00/share through September 30, 2027.
- Trust now beneficially owns 9,491,270 shares, representing 24.5% of outstanding Class A Common Stock (based on 29,283,614 shares outstanding as of June 30, 2026).
- Board Rights Agreement: board fixed at five directors; Trust can designate two. Philip Barach appointed to board on September 24, 2026.
- Trust obtained first-priority security interest over substantially all assets of Celularity and its material subsidiaries.
- Existing $3M convertible note (Dec 2025) amended: maturity extended to Sept 2028, conversion price reduced from $1.66 to $1.50/share; related warrants amended to $1.50 exercise price.
- Company is not in compliance with Nasdaq listing rules due to late filings and low market value (per cross-filing 8-K).
Financial Impact
Trust injected $3.21M in new capital via secured convertible note; has option for up to $2.92M more. Trust's total potential exposure including amended existing note is ~$6.13M in principal. The secured position covers substantially all assets.
Risk Factors
- Massive potential dilution: the Trust's convertible notes and warrants could convert into up to ~9.5M shares (already 24.5% of outstanding), with additional potential from the option tranche.
- Company is not compliant with Nasdaq listing rules and has not timely filed Q1 and Q2 2026 10-Qs, increasing risk of delisting.
- Activist's secured position gives it priority over other creditors in a bankruptcy scenario, potentially forcing other stakeholders to take losses.
- Board control by activist could lead to aggressive actions (asset sales, reverse mergers) that may not benefit minority common shareholders.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001104659-26-111279 |
| Document: 0001104659-26-111279-index-headers.html | 0001104659-26-111279 |
| Document: 0001104659-26-111279-index.html | 0001104659-26-111279 |
| Document: 0001104659-26-111279.txt | 0001104659-26-111279 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 10-K/A | $1.26 | awaiting T+60 | — | $0.9457 (+24.94%) |
Sep 30, 2026 26d ago | Press Release | $1.35 | awaiting T+60 | — | $0.9457 (−29.95%) |
Sep 29, 2026 26d ago | 8-K | $1.35 | awaiting T+60 | — | $0.9457 (−29.95%) |
Sep 28, 2026 27d ago | SC 13D/A | $1.40 | awaiting T+60 | — | $0.9457 (+32.45%) |
Sep 28, 2026 28d ago | 8-K | $1.40 | awaiting T+60 | — | $0.9457 (+32.45%) |
Sep 24, 2026 4w ago | Press Release | $1.32 | awaiting T+60 | — | $0.9457 (−28.36%) |
Sep 14, 2026 6w ago | 8-K | $1.40 | awaiting T+60 | — | $0.9457 (−32.45%) |
Aug 25, 2026 8w ago | Press Release | $0.8804 | awaiting T+60 | — | $0.9457 (−7.42%) |
Aug 7, 2026 11w ago | 8-K | $0.6866 | awaiting T+60 | — | $0.9457 (−37.74%) |
Jun 30, 2026 16w ago | 8-K | $0.5979 $1.15 | ▼ −92.34% | ▼ −88.78% | $0.9457 (−58.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers